Oracle mHealth Platform is Revolutionizing Clinical Trials with Remote Monitoring Devices

Oracle mHealth is revolutionizing clinical trials with remote monitoring devices.

Image: Freepik

Many clinical trials get delayed or even cancelled due to problems with patient recruitment. Many patients cannot be recruited because of their locations in relation to the investigation sites. No participant would want to go to the trial location, driving through rush hour traffic to have their blood pressure checked. Large and scattered patient populations for a given trial are often outside of a reasonable commuting distance from a site; hence, they never volunteer.

Related Verisense™ Wearable Sensor Platform for Clinical Trials – Interview with Geoff Gill, president of Shimmer Americas

However, the Internet of Things (IoT) is revolutionizing clinical research. Oracle’s connected medical devices can remotely gather clinical data from patients. Oracle solutions capture and analyze that data to give researchers a real-time view of patient progress.

“Our goal is to simplify adoption of new technologies. For clinical program managers, protocol designers, and therapeutic leads, our concept is to simplify choosing the right wearable/sensor/app/ source(s) that make sense for their trials and rapidly move into patient recruitment mode,” reports Oracle.

Each clinical trial participant wears a connected mHealth sensor with a unique identifier. The device remotely and continuously collects real-world patient data, such as blood pressure and blood glucose levels, and then sends the information, via Bluetooth, to the patient’s mobile device. From there, the data is routed through Oracle Health Sciences mHealth Connector Cloud Service, an enterprise-class, highly secure, scalable, integration platform that aggregates, summarizes, and disseminates the targeted data into Oracle Health Sciences InForm or Oracle Health Sciences Data Management Workbench (DMW).

This single platform reduces the number of technical integration points, optimizes third-party vendor interactions, and simplifies the way clinical trial teams can embrace new methods as part of a digital trial program.

Related Garmin Health Partners with ActiGraph to Create Wearables for Clinical Trials

“We at Oracle Heath Sciences are very excited about this new platform, and the opportunity it provides for the industry to embrace remote patient monitoring and virtual trial methodologies at scale across all clinical trials. We look forward to sharing more of our vision for digital trials with you,” says Oracle.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, Viewpointsystem and many more. Register now to be part of #WTUS19

Sam Draper
April 30, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Former Texas Instruments Executive Bing Xie Appointed as an Independent Director at Huami’s Board

Huami announced that it appointed Mr. Bing Xie, former Texas Instruments executive officer and...

LAWK ONE: AR Glasses for Outdoor Adventure

LAWK ONE AR glasses overlay virtual information onto the real world through its intelligent display.

Conjoined Twins Separated With Help Of VR

After nearly four years in hospital, it was possible to separate the twins in a 27h lasting surgery.

Posture and Tech Company Posture360 Launches Crowdfunding EOI with Birchal

Back pain is the most common cause of disability worldwide, and it’s also the number two reason....
Discover more